Skip to main content Back to Top
Advertisement

7/12/2021

Hydroxyzine Pamoate Oral Capsules

Products Affected - Description

    • Vistaril oral capsule, Pfizer, 25 mg, bottle, 100 count, NDC 00069-5410-66
    • Hydroxyzine pamoate oral capsule, Amneal, 25 mg, bottle, 500 count, NDC 00115-1803-02
    • Hydroxyzine pamoate oral capsule, Amneal, 50 mg, bottle, 500 count, NDC 00115-1804-02
    • Hydroxyzine pamoate oral capsule, Avet Pharmaceuticals, 25 mg, bottle, 100 count, NDC 14539-0674-01
    • Hydroxyzine pamoate oral capsule, Avet Pharmaceuticals, 25 mg, bottle, 500 count, NDC 14539-0674-05
    • Hydroxyzine pamoate oral capsule, Avet Pharmaceuticals, 50 mg, bottle, 100 count, NDC 14539-0675-01
    • Hydroxyzine pamoate oral capsule, Avet Pharmaceuticals, 50 mg, bottle, 500 count, NDC 14539-0675-05

Reason for the Shortage

    • Amneal did not provide a reason for the shortage.
    • Avet did not provide a reason for the shortage.
    • Pfizer has Vistaril on shortage due to manufacturing delays.
    • Sandoz has hydroxyzine pamoate capsules available.
    • Teva has hydroxyzine pamoate capsules available.

Available Products

    • Vistaril oral capsule, Pfizer, 50 mg, bottle, 100 count, NDC 00069-5420-66
    • Hydroxyzine pamoate oral capsule, Amneal, 25 mg, bottle, 100 count, NDC 00115-1803-01
    • Hydroxyzine pamoate oral capsule, Amneal, 50 mg, bottle, 100 count, NDC 00115-1804-01
    • Hydroxyzine pamoate oral capsule, Sandoz, 25 mg, bottle, 100 count, NDC 00185-0674-01
    • Hydroxyzine pamoate oral capsule, Sandoz, 25 mg, bottle, 500 count, NDC 00185-0674-05
    • Hydroxyzine pamoate oral capsule, Sandoz, 50 mg, bottle, 100 count, NDC 00185-0615-01
    • Hydroxyzine pamoate oral capsule, Sandoz, 50 mg, bottle, 500 count, NDC 00185-0615-05
    • Hydroxyzine pamoate oral capsule, Teva, 100 mg, bottle, 100 count, NDC 00555-0324-02
    • Hydroxyzine pamoate oral capsule, Teva, 25 mg, bottle, 100 count, NDC 00555-0323-02
    • Hydroxyzine pamoate oral capsule, Teva, 25 mg, bottle, 500 count, NDC 00555-0323-04
    • Hydroxyzine pamoate oral capsule, Teva, 50 mg, bottle, 100 count, NDC 00555-0302-02
    • Hydroxyzine pamoate oral capsule, Teva, 50 mg, bottle, 500 count, NDC 00555-0302-04

Estimated Resupply Dates

    • Avet has all hydroxyzine pamoate presentations on allocation.
    • Amneal has hydroxyzine pamoate 25 mg and 50 mg capsules in 500 count bottles available with short expiration dating.
    • Pfizer has Vistaril 25 mg capsules in 100 count bottles on back order and the company estimates a release date of August 2021.

Updated

Updated July 12, 2021 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 14, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.